share_log

ImmunoPrecise Antibodies Q1 Sales $4.70M Beat $4.02M Estimate

ImmunoPrecise Antibodies Q1 Sales $4.70M Beat $4.02M Estimate

免疫精抗体第一季度销售额470万美元超过预期402万美元
Benzinga Real-time News ·  2022/09/14 08:08

ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly sales of $4.70 million which beat the analyst consensus estimate of $4.02 million by 16.92 percent. This is a 25.87 percent increase over sales of $3.73 million the same period last year.

免疫精抗体公司(纳斯达克代码:IPA)公布季度销售额为470万美元,比分析师一致预期的402万美元高出16.92%。这比去年同期373万美元的销售额增长了25.87%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发